Methylenedioxymethamphetamine (mdma) and methylenedioxyamphetamine (MDA) reagent kits
Ended Awarded Last action
- Contract number
- N6854626FA008
- Awardee
-
Microgenics Corporation UEI E7WGWEK19Y79
- Awarding agency
-
Bureau of Medicine and Surgery
Department of the Navy, Department of Defense
- Obligated
- $15,022
Award facts
- Contract value 100% obligated
- $15,022.08 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- Set-aside
- No set-aside
- Competition
- Competed under SAP Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Pomona, CA 91767, USA
Award details come from SAM.gov/FPDS.
About this award
The U.S. Navy Bureau of Medicine and Surgery awarded a $15,022.08 firm fixed-price delivery order to Microgenics Corporation on January 9, 2026, for methylenedioxymethamphetamine (MDMA) and methylenedioxyamphetamine (MDA) reagent kits. The contract, with an ultimate completion date of February 10, 2026, will be performed at Microgenics' Clinical Diagnostics Division facility in Pomona, California. This delivery order was awarded without a set-aside designation, reflecting the contractor's competitive standing in the federal marketplace. Microgenics Corporation, a subsidiary of Thermo Electron Corporation, specializes in clinical diagnostic products and toxicology testing solutions used across military and veterans healthcare systems.
This delivery order supports the Department of Defense Drug Demand Reduction Program by providing critical diagnostic reagents for substance abuse testing. Microgenics holds multiple significant indefinite delivery contracts with the Navy Bureau of Medicine and Surgery and other federal healthcare agencies, including a $1.15 million contract specifically for MDMA/MDA reagent kits, underscoring the company's established role as a key supplier of immunoassay reagent test kits for controlled substance detection. The contractor has demonstrated consistent capability in delivering high-precision diagnostic solutions across a diverse portfolio of substance identification products, including opiates, benzodiazepines, and amphetamines.
Quick answers
Who was awarded contract N6854626FA008?
N6854626FA008 was awarded to Microgenics Corporation by Bureau of Medicine and Surgery (Department of the Navy) on January 9, 2026.
How much is contract N6854626FA008 worth?
The government has obligated $15,022 on N6854626FA008.
Is contract N6854626FA008 an order under another contract?
Yes. N6854626FA008 is a delivery order under N0018924DZ018, an indefinite delivery contract.
Was contract N6854626FA008 competed?
The extent of competition for N6854626FA008 was competed under sap.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award